Hui Ling
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA Interference and Gene Delivery
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 14
- RNA modifications and cancer 12
- RNA Research and Splicing 6
- DNA Repair Mechanisms 4
- Phytochemical compounds biological activities 4
-
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 20
- Co-authors
- George A. Călin (19 shared papers)Muller Fabbri (1 shared paper)Martin Pichler (14 shared papers)Masahisa Ohtsuka (4 shared papers)Ioana Berindan‐Neagoe (3 shared papers)Riccardo Fodde (2 shared papers)Yaochun Zhang (4 shared papers)Ken R. Vincent (1 shared paper)
- Journals
- Clinica Chimica Acta (5 papers)Oncotarget (5 papers)International Journal of Molecular Sciences (5 papers)Cancer Research (3 papers)Molecular Carcinogenesis (3 papers)
- Partner nations
- United StatesChinaAustria
In The Last Decade
Hui Ling
77 papers receiving 4.4k citations
Hui Ling's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 2.4k
- Molecular Biology 2.8k
- Pharmacology 185
- Oncology 543
- Pathology and Forensic Medicine 217
Countries citing papers authored by Hui Ling
This map shows the geographic impact of Hui Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ling more than expected).
Fields of papers citing papers by Hui Ling
This network shows the impact of papers produced by Hui Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ling. The network helps show where Hui Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNAs and other non-coding RNAs as targets for anticancer drug development Hit paper breakdown → | 2013 | 1246 |
| 2 | 2015 | 272 | |
| 3 | 2014 | 166 | |
| 4 | 2010 | 162 | |
| 5 | 2013 | 158 | |
| 6 | 2015 | 148 | |
| 7 | 2018 | 132 | |
| 8 | 2014 | 130 | |
| 9 | 2015 | 110 | |
| 10 | 2008 | 103 | |
| 11 | 2014 | 89 | |
| 12 | 2010 | 71 | |
| 13 | 2014 | 68 | |
| 14 | 2018 | 67 | |
| 15 | 2016 | 65 | |
| 16 | 2016 | 62 | |
| 17 | 2016 | 62 | |
| 18 | 2015 | 61 | |
| 19 | 2016 | 60 | |
| 20 | 2019 | 58 |
About Hui Ling
Hui Ling is a scholar working on Molecular Biology, Cancer Research, Oncology, Plant Science and Pathology and Forensic Medicine, having authored 81 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (14 papers), Garlic and Onion Studies (12 papers), RNA modifications and cancer (12 papers), RNA Research and Splicing (6 papers), DNA Repair Mechanisms (4 papers) and Phytochemical compounds biological activities (4 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (2.8k citations), Pharmacology (185 citations), Oncology (543 citations) and Pathology and Forensic Medicine (217 citations). Hui Ling has collaborated with scholars based in United States, China and Austria. Frequent co-authors include George A. Călin, Muller Fabbri, Martin Pichler, Masahisa Ohtsuka, Ioana Berindan‐Neagoe, Riccardo Fodde, Yaochun Zhang, Ken R. Vincent, Frank J. Slack and Xi Zeng. Their work appears in journals such as Clinica Chimica Acta, Oncotarget, International Journal of Molecular Sciences, Cancer Research and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.